Gthx forecast
WebApr 12, 2024 · Zacks Equity Research. G1 Therapeutics (GTHX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend ... WebApr 4, 2024 · GTHX Signals & Forecast. A buy signal was issued from a pivot bottom point on Thursday, April 06, 2024, and so far it has risen …
Gthx forecast
Did you know?
WebApr 11, 2024 · G1 Therapeutics (GTHX) stock Forecast for 2024 – 2026. Last update: April 11, 2024 (12:23) Sector: Healthcare. The share price of G1 Therapeutics, Inc. (GTHX) … WebJul 31, 2024 · Shareholders in G1 Therapeutics, Inc. (NASDAQ:GTHX) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The consensus estimated revenue ...
WebApr 10, 2024 · What are analysts’ forecasts for GTHX stock? Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GTHX stock … WebACHR Earnings Forecast. Next quarter’s earnings estimate for ACHR is -$0.33 with a range of -$0.35 to -$0.29. The previous quarter’s EPS was -$0.35. ACHR beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 62.05% of the time in the same period.
WebApr 11, 2024 · Additionally, it is anticipated that during the forecast period 2024-2031, the expansion of the packaging industry in several emerging economies, including China, India, Japan, and Europe, as well ... WebMar 2, 2024 · G1 Therapeutics Inc. (NASDAQ:GTHX) shares, rose in value on Wednesday, 03/01/23, with the stock price up by 1.38% to the previous day’s close as strong demand from buyers drove the stock to $3.67. ... According to the average forecast, sales growth in current quarter could jump up 69.60%, compared to the corresponding quarter of last …
WebSee G1 Therapeutics, Inc. (GTHX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
WebApr 5, 2024 · Their GTHX share price forecasts range from $10.00 to $25.00. On average, they expect the company's stock price to reach $16.60 in the next year. This suggests a … According to the issued ratings of 6 analysts in the last year, the consensus rating for … According to the Securities & Exchange Commission (SEC) insider trading … Are you trading options on G1 Therapeutics (NASDAQ:GTHX)? View the latest … GTHX has generated -$3.39 earnings per share over the last four quarters. What … Date Filer Form Type View; 04/13/2024 12:50 PM: Morgan Stanley … G1 Therapeutics, Inc.'s (NASDAQ:GTHX) latest 46% decline adds to one-year … smith 1010WebApr 12, 2024 · GTHX Earnings Date and Information. G1 Therapeutics last issued its quarterly earnings results on March 1st, 2024. The reported ($0.73) earnings per share … rite aid hemorrhoid wipesWebThe 6 analysts offering 1 year price forecasts for GTHX have a max estimate of — and a min estimate of —. Analyst rating Based on 8 analysts giving stock ratings to GTHX in … rite aid hemorrhoid treatmentWebMar 1, 2024 · Earnings announcement* for GTHX: Mar 01, 2024. G1 Therapeutics, Inc. is expected* to report earnings on 03/01/2024 before market open. The report will be for … smith 1020WebApr 10, 2024 · 2 brokerages have issued 12 month price targets for Cyclacel Pharmaceuticals' stock. Their CYCC share price forecasts range from $8.00 to $8.00. On average, they predict the company's stock price to reach $8.00 in the next year. This suggests a possible upside of 1,233.3% from the stock's current price. View analysts … rite aid hepatitis b vaccineWebApr 6, 2024 · View G1 Therapeutics GTHX investment & stock information. Get the latest G1 Therapeutics GTHX detailed stock quotes, stock data, Real-Time ECN, charts, stats and … smith 1015WebGTHX Complete G1 Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. smith 1015 drain